Interval Sentinel Lymph Nodes With the Use of Routine Lymphoscintigraphy in Extremity Melanoma.
Humans
Sentinel Lymph Node
/ diagnostic imaging
Lymphoscintigraphy
Retrospective Studies
Lymphatic Metastasis
/ diagnostic imaging
Radionuclide Imaging
Skin Neoplasms
/ diagnostic imaging
Melanoma
/ diagnostic imaging
Lymph Nodes
/ pathology
Sentinel Lymph Node Biopsy
Lymphadenopathy
Upper Extremity
/ diagnostic imaging
Lymph Node Excision
Melanoma, Cutaneous Malignant
Cost-effectiveness
Extremity melanoma
Interval lymph nodes
Lymphoscintigraphy (LS)
Sentinel lymph nodes (SLN)
Journal
The Journal of surgical research
ISSN: 1095-8673
Titre abrégé: J Surg Res
Pays: United States
ID NLM: 0376340
Informations de publication
Date de publication:
01 2024
01 2024
Historique:
received:
02
03
2023
revised:
03
08
2023
accepted:
31
08
2023
medline:
24
11
2023
pubmed:
15
10
2023
entrez:
14
10
2023
Statut:
ppublish
Résumé
Lymphoscintigraphy (LS) helps identify drainage to interval (epitrochlear or popliteal) lymph node basins for extremity melanomas. This study evaluated how often routine LS evaluation identified an interval sentinel lymph node (SLN) and how often that node was found to have metastasis. A single institution, retrospective study identified patients with an extremity melanoma who underwent routine LS and SLN biopsy over a 25-y period. Comparisons of factors associated with the identification of interval node drainage and tumor status were made. In 634 patients reviewed, 5.7% of patients drained to an interval SLN. Of those biopsied, 29.2% were positive for micrometastases. Among patients with biopsies of both the traditional and interval nodal basins, nearly 20% had positive interval nodes with negative SLNs in the traditional basin. Sex, age, thickness, ulceration, and the presence of mitotic figures were not predictive of identifying an interval node on LS, nor for having disease in an interval node. Anatomic location of the primary melanoma was the only identifiable risk factor, as no interval nodes were identified in melanomas of the thigh or upper arm (P ≤ 0.001). Distal extremity melanomas have a moderate risk of mapping to an interval SLN. Routine LS should be considered in these patients, especially as these may be the only tumor-positive nodes. However, primary extremity melanomas proximal to the epitrochlear or popliteal nodal basins do not map to interval nodes, and improved savings and workflow could be realized by selectively omitting routine LS in such patients.
Identifiants
pubmed: 37837816
pii: S0022-4804(23)00495-X
doi: 10.1016/j.jss.2023.08.055
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
613-617Subventions
Organisme : NCI NIH HHS
ID : R25 CA134283
Pays : United States
Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.